Conflict of interest statement: F.C. is one of the principal investigators of theMINDACT trial. The authors declare no competing interests.135. NPJ Breast Cancer. 2018 May 22;4:11. doi: 10.1038/s41523-018-0063-9. eCollection 2018.Prognostic gene expression assays in breast cancer: are two better than one?Sparano JA(1).Author information: (1)Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY USA.DOI: 10.1038/s41523-018-0063-9 PMCID: PMC5964115PMID: 29845110 